Quick Takeaways
- Two Seas Capital LP filed SCHEDULE 13G/A for Esperion Therapeutics, Inc. Common Stock, par value $0.001 per share (ESPR).
- Disclosed ownership: 4.7%.
- Date of event: 30 Sep 2025.
Two Seas Capital LP - 30 Sep 2025 SCHEDULE 13G/A Report for Esperion Therapeutics, Inc. Common Stock, par value $0.001 per share (ESPR)
- Filing Manager
- Two Seas Capital LP
- Reporting Manager
- Two Seas Capital LP
- Symbol
- ESPR
- Shares outstanding
- 207,440,936 shares
- Disclosed Ownership
- 9,749,724 shares
- Ownership
- 4.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 11:43:49 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Two Seas Capital LP disclosed 4.7% ownership in Esperion Therapeutics, Inc. Common Stock, par value $0.001 per share (ESPR) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 14 Nov 2025, 11:43.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Two Seas Capital LP | 4.7% | 9,749,724 | 9,749,724 | 0 | /s/ Sina Toussi | Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner | |
| Two Seas Capital GP LLC | 4.7% | 9,749,724 | 9,749,724 | 0 | /s/ Sina Toussi | Sina Toussi / Managing Member | |
| Sina Toussi | 4.7% | 9,749,724 | 9,749,724 | 0 | /s/ Sina Toussi | Sina Toussi / Self |